Filter Results:
(400)
Show Results For
- All HBS Web
(400)
- News (48)
- Research (309)
- Multimedia (1)
- Faculty Publications (248)
Show Results For
- All HBS Web
(400)
- News (48)
- Research (309)
- Multimedia (1)
- Faculty Publications (248)
- May 2017
- Teaching Note
The CRISPR-Cas9 Quarrel
By: Richard G. Hamermesh and Matthew G. Preble
Teaching Note for HBS No. 817-020. View Details
- 15 Nov 2011
- First Look
First Look: November 15
institutionalize empathy as part of its delivery of care. Purchase this case:http://cb.hbsp.harvard.edu/cb/product/611015-PDF-ENG GoodGuide George Serafeim, Robert G. Eccles, and Tiffany A. ClayHarvard Business School Case 112-031... View Details
Keywords: Sean Silverthorne
- Article
How Harvard Business School Is Advancing Precision Medicine
By: Kathy Giusti and Richard G. Hamermesh
Giusti, Kathy, and Richard G. Hamermesh. "How Harvard Business School Is Advancing Precision Medicine." Journal of Precision Medicine (March 2020).
- March 6, 2020
- Article
How Medical Nonprofits Set Winning Strategy
By: Kathy Giusti and Richard G. Hamermesh
Giusti, Kathy, and Richard G. Hamermesh. "How Medical Nonprofits Set Winning Strategy." Harvard Business Review Digital Articles (March 6, 2020).
- February 25, 2019
- Article
Impact Investing: A New Way to Fund Cures for Cancer
By: Richard G. Hamermesh and Kathy Giusti
Hamermesh, Richard G., and Kathy Giusti. "Impact Investing: A New Way to Fund Cures for Cancer." STAT (February 25, 2019).
- January 2018
- Supplement
The National Football League and Brain Injuries (B)
By: Richard G. Hamermesh and George Riedel
- October 2016 (Revised November 2016)
- Case
Innovating Beyond Ochsner
By: Richard G. Hamermesh and Olivia Hull
The Ochsner Health System has developed a proprietary software tool designed to treat hypertension. Built into the system’s electronic medical records, the Hypertension Digital Medicine program allows patients to record their blood pressure at home and share readings... View Details
Keywords: Electronic Medical Records; Telemedicine; Hypertension; High Blood Pressure; Chronic Disease; Entrepreneurship; Health Disorders; Business Model; Business Startups; Innovation and Invention; Growth Management; Marketing Strategy; Product Launch; Product Positioning; Science-Based Business; Business Strategy; Health Industry; Technology Industry; New Orleans; Louisiana
Hamermesh, Richard G., and Olivia Hull. "Innovating Beyond Ochsner." Harvard Business School Case 817-028, October 2016. (Revised November 2016.)
- June 2015
- Supplement
MINTing Innovation at NewYork-Presbyterian (B)
By: Richard G. Hamermesh and Michael Norris
This short (B) case gives an update on the progress that MINT has made at NYP since the end of the (A) case. View Details
Hamermesh, Richard G., and Michael Norris. "MINTing Innovation at NewYork-Presbyterian (B)." Harvard Business School Supplement 815-113, June 2015.
- March 2015
- Case
Bloodbuy
By: Richard G. Hamermesh and Michael Norris
In 2015, Chris Godfrey, founder and CEO of Bloodbuy, has to consider the best path to growth for his young company, which is attempting to disrupt the blood donation industry. View Details
Keywords: Health Care; Health Care Entrepreneurship; Blood Donation; Health Care and Treatment; Entrepreneurship; Health Industry; United States
Hamermesh, Richard G., and Michael Norris. "Bloodbuy." Harvard Business School Case 815-114, March 2015.
- July 2012 (Revised May 2024)
- Case
Lyric Dinner Theater (A)
By: Richard G. Hamermesh and Jim Sharpe
Looking back at five years of losses, Rivka Belzer, a newly minted MBA, steps into her family owned business with their mandate to turn it around or close it. In her first six months, she has made a number of changes, with mixed results, but is beginning to show a... View Details
Keywords: Entrepreneurs; Entrepreneurial Management; Crisis Management; Family Business; Turnarounds; Financial Crisis; Boards Of Directors; Operations Management; Strategy Implementation; Career Planning; Entrepreneurship; Entertainment and Recreation Industry; United States
Hamermesh, Richard G., and Jim Sharpe. "Lyric Dinner Theater (A)." Harvard Business School Case 813-043, July 2012. (Revised May 2024.)
- December 2008 (Revised October 2013)
- Case
Amylin Pharmaceuticals: Diabetes and Beyond (A)
By: Richard G. Hamermesh and Rachel Gordon
Ginger Graham, CEO of Amylin Pharmaceuticals, joined the company with the expectation of taking the company's signature drug, Symlin, to market. However, unforeseen regulatory challenges have put the approval process in jeopardy. At the same time, the company has a... View Details
Keywords: Regulations; Drug Regulations; Symlin; Negotiation; Governing Rules, Regulations, and Reforms; Resource Allocation; Negotiation Deal; Product Development; Research and Development; Commercialization; Pharmaceutical Industry; United States
Hamermesh, Richard G., and Rachel Gordon. "Amylin Pharmaceuticals: Diabetes and Beyond (A)." Harvard Business School Case 809-011, December 2008. (Revised October 2013.)
- September 2007 (Revised May 2009)
- Case
Syndexa and Technology Transfer at Harvard University
By: Richard G. Hamermesh and David Kiron
Gokhan Hotamisligil is a star researcher at Harvard School of Public Health who has made groundbreaking discoveries linking fat cells, inflammation, and diabetes. He now wants to form a company to commercialize these discoveries. At the same time, Isaac Kohlberg, the... View Details
Keywords: Business Startups; Higher Education; Entrepreneurship; Innovation and Invention; Intellectual Property; Rights; Agreements and Arrangements; Science-Based Business; Commercialization; Biotechnology Industry; Health Industry
Hamermesh, Richard G., and David Kiron. "Syndexa and Technology Transfer at Harvard University." Harvard Business School Case 808-073, September 2007. (Revised May 2009.)
- March 2006
- Teaching Note
Cutlass Capital, L.P. (TN)
By: Richard G. Hamermesh and Erin Seefeld
Teaching Note to 805075. View Details
Keywords: Financial Services Industry
- March 2006
- Teaching Note
Fred Khosravi and AccessClosure (TN)
By: Richard G. Hamermesh and Erin Seefeld
Teaching Note to (806-044). View Details
- January 2006 (Revised May 2007)
- Case
Endo Pharmaceuticals (A): From LBO to...?
By: Richard G. Hamermesh and Brian DeLacey
Endo Pharmaceuticals was formed in 1997 as a leveraged buyout spin-off from DuPont Merck. In 1999, it must decide whether to do an IPO or merge with a smaller company. View Details
Keywords: Private Equity; Initial Public Offering; Leveraged Buyouts; Mergers and Acquisitions; Health Care and Treatment; Pharmaceutical Industry; United States
Hamermesh, Richard G., and Brian DeLacey. "Endo Pharmaceuticals (A): From LBO to...?" Harvard Business School Case 806-064, January 2006. (Revised May 2007.)
- January 2002 (Revised July 2002)
- Teaching Note
Vialog Corporation (TN)
By: Richard G. Hamermesh and Michele Lutz
- January 2001 (Revised April 2001)
- Case
Lawyers & Leases
By: Richard G. Hamermesh and Michele Lutz
Profiles Rajath Chaundry, an aspiring entrepreneur, as he attempts to secure office space for his growing team, select a lawyer, and continue to build his fledgling enterprise, eLearning.com. Designed to be used in an entrepreneurial management or small business course... View Details
Keywords: Entrepreneurship; Business or Company Management; Business Ventures; Corporate Entrepreneurship; Intellectual Property; Management Succession; Leasing; Negotiation; Education Industry; Legal Services Industry
Hamermesh, Richard G., and Michele Lutz. "Lawyers & Leases." Harvard Business School Case 801-166, January 2001. (Revised April 2001.)
- December 1998 (Revised May 1999)
- Case
Specialty Medical Chemicals
By: Richard G. Hamermesh and Lucinda Doran
A new general manager is supposed to rekindle growth. Seven months later, he questions the abilities of his direct reports. An organizational psychologist is brought in to assess his people. The general manager now has to decide who to keep and how to structure his... View Details
Keywords: Decisions; Employees; Leadership Development; Management Teams; Organizational Structure; Cognition and Thinking
Hamermesh, Richard G., and Lucinda Doran. "Specialty Medical Chemicals." Harvard Business School Case 399-094, December 1998. (Revised May 1999.)
- November 1981 (Revised May 1985)
- Case
General Electric: Business Development
By: Francis Aguilar and Richard G. Hamermesh
Aguilar, Francis, and Richard G. Hamermesh. "General Electric: Business Development." Harvard Business School Case 382-092, November 1981. (Revised May 1985.)